Simon R. Bushell

Simon R. Bushell

Auto-generated profile, based on publicly available information

Simon R. Bushell

University of Oxford, Centre for Medicines Discovery

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
SBSimon R. Bushell
Simon R. Bushell
APAshley C. W. Pike
Ashley C. W. Pike
MFMaria E. Falzone
Maria E. Falzone
NRNils J. G. Rorsman
Nils J. G. Rorsman
CTChau M. Ta
Chau M. Ta
ECElisabeth P. Carpenter
Elisabeth P. Carpenter
Membranes in cells have defined distributions of lipids in each leaflet, controlled by lipid scramblases and flip/floppases. However, for some intracellular membranes such as the endoplasmic reticulum (ER) the scramblases have not been identified. Members of the TMEM16 family have either lipid scramblase or chloride channel activity. Although TMEM16K is widely distributed and associated with the neurological disorder autosomal recessive spinocerebellar ataxia type 10 (SCAR10), its location in cells, function and structure are largely uncharacterised. Here we show that TMEM16K is an ER-resident lipid scramblase with a requirement for short chain lipids and calcium for robust activity. Crystal structures of TMEM16K show a scramblase fold, with an open lipid transporting groove. Additional cryo-EM structures reveal extensive conformational changes from the cytoplasmic to the ER side of the membrane, giving a state with a closed lipid permeation pathway. Molecular dynamics simulations showed that the open-groove conformation is necessary for scramblase activity.

28 October 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HLHubing Lou
Hubing Lou
MCMin Chen
Min Chen
SBSusan S. Black
Susan S. Black
SBSimon R. Bushell
Simon R. Bushell
MCMatteo Ceccarelli
Matteo Ceccarelli
JNJames H Naismith
James H Naismith
Antibiotic-resistant bacteria, particularly Gram negative species, present significant health care challenges. The permeation of antibiotics through the outer membrane is largely effected by the porin superfamily, changes in which contribute to antibiotic resistance. A series of antibiotic resistant E. coli isolates were obtained from a patient during serial treatment with various antibiotics. The sequence of OmpC changed at three positions during treatment giving rise to a total of four OmpC variants (denoted OmpC20, OmpC26, OmpC28 and OmpC33, in which OmpC20 was derived from the first clinical isolate). We demonstrate that expression of the OmpC K12 porin in the clinical isolates lowers the MIC, consistent with modified porin function contributing to drug resistance. By a range of assays we have established that the three mutations that occur between OmpC20 and OmpC33 modify transport of both small molecules and antibiotics across the outer membrane. This results in the modulation of resistance to antibiotics, particularly cefotaxime. Small ion unitary conductance measurements of the isolated porins do not show significant differences between isolates. Thus, resistance does not appear to arise from major changes in pore size. Crystal structures of all four OmpC clinical mutants and molecular dynamics simulations also show that the pore size is essentially unchanged. Molecular dynamics simulations suggest that perturbation of the transverse electrostatic field at the constriction zone reduces cefotaxime passage through the pore, consistent with laboratory and clinical data. This subtle modification of the transverse electric field is a very different source of resistance than occlusion of the pore or wholesale destruction of the transverse field and points to a new mechanism by which porins may modulate antibiotic passage through the outer membrane.

1 June 2009 in Immunity
Verified
Journal Article
Closed access
Travis BeddoeTravis Beddoe
Travis Beddoe
ZCZhenjun Chen
Zhenjun Chen
CCCraig S. Clements
Craig S. Clements
LELauren K. Ely
Lauren K. Ely
SBSimon R. Bushell
Simon R. Bushell
JRJamie Rossjohn
Jamie Rossjohn

1 November 2018 in Cell
Verified
Journal Article
Open access
Yin Yao DongYin Yao Dong
Yin Yao Dong
HWHua Wang
Hua Wang
APAshley C.W. Pike
Ashley C.W. Pike
SCStephen A. Cochrane
Stephen A. Cochrane
SHSadra Hamedzadeh
Sadra Hamedzadeh
ECElisabeth P. Carpenter
Elisabeth P. Carpenter
Protein N-glycosylation is a widespread post-translational modification. The first committed step in this process is catalysed by dolichyl-phosphate N-acetylglucosamine-phosphotransferase DPAGT1 (GPT/E.C. 2.7.8.15). Missense DPAGT1 variants cause congenital myasthenic syndrome and disorders of glycosylation. In addition, naturally-occurring bactericidal nucleoside analogues such as tunicamycin are toxic to eukaryotes due to DPAGT1 inhibition, preventing their clinical use. Our structures of DPAGT1 with the substrate UDP-GlcNAc and tunicamycin reveal substrate binding modes, suggest a mechanism of catalysis, provide an understanding of how mutations modulate activity (thus causing disease) and allow design of non-toxic "lipid-altered" tunicamycins. The structure-tuned activity of these analogues against several bacterial targets allowed the design of potent antibiotics for Mycobacterium tuberculosis, enabling treatment in vitro, in cellulo and in vivo, providing a promising new class of antimicrobial drug.

1 May 2013 in Structure
Verified
Journal Article
Open access
SBSimon R. Bushell
Simon R. Bushell
IMIain Mainprize
Iain Mainprize
MWMartin A. Wear
Martin A. Wear
HLHubing Lou
Hubing Lou
CWChris Whitfield
Chris Whitfield
JNJames H Naismith
James H Naismith
Many pathogenic bacteria encase themselves in a polysaccharide capsule that provides a barrier to the physical and immunological challenges of the host. The mechanism by which the capsule assembles around the bacterial cell is unknown. Wzi, an integral outer-membrane protein from Escherichia coli, has been implicated in the formation of group 1 capsules. The 2.6 Å resolution structure of Wzi reveals an 18-stranded β-barrel fold with a novel arrangement of long extracellular loops that blocks the extracellular entrance and a helical bundle that plugs the periplasmic end. Mutagenesis shows that specific extracellular loops are required for in vivo capsule assembly. The data show that Wzi binds the K30 carbohydrate polymer and, crucially, that mutants functionally deficient in vivo show no binding to K30 polymer in vitro. We conclude that Wzi is a novel outer-membrane lectin that assists in the formation of the bacterial capsule via direct interaction with capsular polysaccharides.

1 December 2009 in Journal of Molecular Biology
Verified
Journal Article
Closed access
JVJulian P. Vivian
Julian P. Vivian
JSJessica Scoullar
Jessica Scoullar
KRKieran Rimmer
Kieran Rimmer
SBSimon R. Bushell
Simon R. Bushell
Travis BeddoeTravis Beddoe
Travis Beddoe
MSMartin J. Scanlon
Martin J. Scanlon